CTAD 2024 Conference Schedule Highlights

The Clinical Trials on Alzheimer's Disease (CTAD) conference kicks off in Madrid this month and ATRI leadership is excited to be involved with many of the sessions. CTAD is the only conference that brings together the world’s leading AD/ADRD clinical trialists working in academia, industry, and not-for-profit organizations and has a focus on Alzheimer’s Disease therapeutic trials.

Below you'll find a list of key sessions the ATRI leadership helped make possible, and which will provide unique insights into some of the work being done by ATRI and their collaborators. You can register to attend the event virtually here. And you can view the entire CTAD conference schedule here.

Tuesday, Oct 29th

  • 4:00 p.m.: Opening Ceremony includes Paul Aisen.
  • 4:55 p.m.: Oral Communications includes Paul Aisen.
  • 6:10 p.m. Late breaking Symposium 1 - The AHEAD 3-45 Study: Design and Results of a Novel Screening Process for a Preclinical AD Trial includes Rema Raman.
    Presentation 1: The AHEAD 3-45 Study: Adaptation to Challenges includes Paul Aisen.
    Presentation 3: Racial and Ethnic Differences in Plasma P-tau217 Biomarker Eligibility Rates in a Preclinical AD Trial includes Doris Molina Henry.

Friday, Nov 1st


CTAD is also dedicated to promoting the professional development of early career investigators on a career track as an AD/ADRD therapeutic trials clinical investigator or principal investigator. On Wednesday, October 30th at 10:20 a.m., Robert Rissman will co-moderate Showcase A for early career investigators, on Thursday, October 31st at 10:55 a.m., Rema Raman will co-moderate Showcase C, and on Thursday, October 31st at 3:55 p.m., Mike Rafii will co-moderate Showcase D.

 

9860 Mesa Rim Road,
San Diego, CA 92121
ATRIinfo@usc.edu
Phone: (858) 964-4644
Fax: (858) 622-1904

Sign up for our Newsletter

Stay up to date with the latest news in Alzheimer’s theraputics.